Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Post-PE Syndrome and Transcatheter Therapy
Author(s): Belén Biscotti Rodil , Juan Duarte Torres , Irene Martín de Miguel , et al Added: 1 month ago

Heart Failure
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 1 year ago

Anticoagulation

Intervention
Acute Coronary Syndrome Post-TAVR with Dr Samineh Sehatbakhsh
Author(s): Samineh Sehatbakhsh Added: 5 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients… View more

Intervention
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 10 months ago

Anticoagulation

MI/ACS
EuroPCR 25: The OCCUPI Trial
Author(s): Byeong-Keuk Kim Added: 8 months ago
EuroPCR 25 - Subgroup analysis outcomes from OCCUPI show optical coherence tomography-guided percutaneous coronary intervention (PCI) is an effective intravascular imaging technique for complex lesions, having successfully met its composite primary outcome measure.We are joined by Dr Byeong-Keuk Kim (Yonsei University College of Medicine, Seoul, KR) to discuss subgroup analysis findings from the… View more

Intervention

MI/ACS
Individualising Antithrombotic Strategies for ACS and CCS
Author(s): Robert F Storey Added: 1 year ago

Anticoagulation

Intervention
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 2 years ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

Intervention

MI/ACS
Mikhail Kosiborod
Job title: Professor of Medicine
Dr Mikhail Kosiborod is a cardiologist based in the United States, where he serves as Senior Vice President, Late-stage Development, CVRM at AstraZeneca and Professor of Medicine at the University of Missouri–Kansas City. He is internationally recognised for his work at the intersection of cardiovascular disease, diabetes, and metabolic disorders, and has built a career that integrates clinical… View more
AQUATIC Trial: Aspirin Plus Anticoagulation Harmful in High-Risk Chronic Coronary Syndrome
Added: 5 months ago Source:  Radcliffe Cardiology
Adding aspirin to an oral anticoagulant (OAC) regimen results in a higher risk of ischaemic events, all-cause mortality, and major bleeding in patients with chronic coronary syndrome (CCS) at high atherothrombotic risk, according to the results of the AQUATIC trial.¹ The study was stopped early due to an excess of deaths in the aspirin group.The AQUATIC trial was a multicentre, double-blind,… View more

Anticoagulation

Intervention
Thomas Kahan
Dr Thomas Kahan is Senior consultant in cardiolgy at the Department of cardiology, Danderyd University Hospital Dr Kahan is on the Editorial Board of European Cardiology Review. Research Interests Neurohormonal control of blood pressure and cardiac function in man. Specifically, we study how the sympatho-adrenal mechanisms and the renin-angiotensin-aldosterone system influence… View more